semaglutide being banned A South African court has ordered pharmacy group iDexis to stop selling semaglutide-based medicines. The ruling follows a legal challenge by Novo Nordisk, maker of Ozempic and Wegovy. Novo alleged the company Compounded Semaglutide Ban Status &

HUBERMAN: In fact, one way that BPC-157 creates this increase in angiogenesis, this increase in vasculature, is through upregulation of something called VEGF, V-E-G-F, which is vascular endothelial growth factor

But limited access to approved medications does not make an unapproved product equivalent, nor should patients be forced to choose between receiving no care and accepting avoidable uncertainty about the contents and quality of a medication

First cardiovascular safety trial of a DPP-4 inhibitor in patients with T2DM and high cardiovascular risk, showing that saxagliptin does not augment MACE but increases hospitalization for heart failure

Important Caveat: Gastric Sleeve Is Excellent, But Not Perfect for Everyone A good bariatric surgeon should never oversimplify the decision

Analysis of Km23-1(DYNRB1) Interacting Proteins By Mass Spectrometry